FocalTherics ADR (FOCL): Next-Year EPS Estimate 25.16%
As of 2026-06-02, FocalTherics ADR (FOCL) has a next-year EPS growth estimate of 25.16%.
FOCL was first flagged by our screen on 2026-06-01 with a next-year EPS growth estimate of 25.16%. Current-year growth is projected at -11.79%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Distribution
- EPS growth next year
- 25.16%
- EPS growth this year
- -11.79%
- EPS next quarter (est)
- -$0.23
- Last price
- $4.72
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-02 | 25.16% | -11.79% | -$0.23 | $4.72 |
| 2026-06-01 | 25.16% | -11.79% | -$0.23 | $4.78 |
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is FocalTherics ADR's next-year EPS growth estimate?▾
As of 2026-06-02, FocalTherics ADR (FOCL) has a next-year EPS growth estimate of 25.16%, based on analyst consensus.
What sector and industry does FocalTherics ADR belong to?▾
FocalTherics ADR operates in the Healthcare sector, specifically the Medical Distribution industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. FOCL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. FocalTherics ADR (FOCL) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports